J. Safra Sarasin Holding AG Buys 28,114 Shares of Intuitive Surgical, Inc. $ISRG

J. Safra Sarasin Holding AG increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 173.4% during the second quarter, HoldingsChannel.com reports. The firm owned 44,330 shares of the medical equipment provider’s stock after acquiring an additional 28,114 shares during the quarter. J. Safra Sarasin Holding AG’s holdings in Intuitive Surgical were worth $24,089,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of ISRG. TFG Advisers LLC lifted its stake in shares of Intuitive Surgical by 6.6% in the second quarter. TFG Advisers LLC now owns 997 shares of the medical equipment provider’s stock worth $542,000 after buying an additional 62 shares in the last quarter. ASR Vermogensbeheer N.V. raised its holdings in shares of Intuitive Surgical by 16.0% during the second quarter. ASR Vermogensbeheer N.V. now owns 28,379 shares of the medical equipment provider’s stock valued at $15,421,000 after purchasing an additional 3,909 shares during the last quarter. Platinum Investment Management Ltd. bought a new position in Intuitive Surgical during the second quarter valued at approximately $211,000. EWA LLC boosted its holdings in Intuitive Surgical by 7.9% in the second quarter. EWA LLC now owns 667 shares of the medical equipment provider’s stock worth $362,000 after purchasing an additional 49 shares during the last quarter. Finally, McGuire Investment Group LLC grew its position in Intuitive Surgical by 2.7% in the 2nd quarter. McGuire Investment Group LLC now owns 24,081 shares of the medical equipment provider’s stock worth $13,086,000 after purchasing an additional 635 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on ISRG shares. Wall Street Zen lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Friday, September 26th. Wells Fargo & Company increased their price objective on shares of Intuitive Surgical from $559.00 to $599.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 23rd. Erste Group Bank restated a “hold” rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Piper Sandler reaffirmed an “overweight” rating and issued a $595.00 target price (up previously from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Finally, Zacks Research lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 20th. Fourteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $594.19.

Intuitive Surgical Stock Performance

ISRG stock opened at $438.04 on Thursday. The firm has a fifty day moving average price of $465.33 and a 200 day moving average price of $500.54. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The firm has a market cap of $157.03 billion, a PE ratio of 61.09, a price-to-earnings-growth ratio of 4.69 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to analysts’ expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business’s revenue was up 21.4% on a year-over-year basis. During the same period last year, the company posted $1.78 EPS. On average, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Transactions at Intuitive Surgical

In related news, Director Amy L. Ladd sold 336 shares of the stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total value of $157,956.96. Following the sale, the director directly owned 1,074 shares of the company’s stock, valued at $504,898.14. This represents a 23.83% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of the business’s stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares of the company’s stock, valued at $173,845.44. This trade represents a 92.73% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 45,224 shares of company stock worth $21,716,492. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.